2015, Pharmaceutical manufacturing and Training

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2015

Pharmaceutical manufacturing

Training

Common pharma compliance concerns cited by FDA warning letters

European Pharmaceutical Review

AUGUST 23, 2022

Warning letters issued by FDA can be an important source of data to study and analyse violations that occur in pharmaceutical manufacturing. Such studies can also help companies prepare for their upcoming inspections by enabling them to identify and rectify any issues.

FDA

FDA Food and Drug Administration Pharma Pharmaceutical manufacturing

FDA warning letters highlight CAPA concerns

European Pharmaceutical Review

AUGUST 10, 2023

Amidst numerous warning letters distributed by the US Food and Drug Administration (FDA) to pharmaceutical manufacturers in recent months, in July this year, the US regulatory body published its analysis on drug product quality in 2022. An FDA warning letter delivered to Edge Biologicals Inc. While RemedyRepack, Inc.

FDA

FDA Food and Drug Administration Media Manufacturing

Pharma Rep Focus

Common pharma compliance concerns cited by FDA warning letters

FDA warning letters highlight CAPA concerns

Stay Connected